Intuitive Surgical receives FDA clearance for the da Vinci 5 robot to be used in cardiac procedures, reports 18% procedure ...

Intuitive Surgical (NasdaqGS:ISRG) received FDA clearance for its da Vinci 5 system to be used in certain cardiac procedures.

With nine new procedures cleared for the da Vinci 5 robot, Intuitive’s strategy includes working with a limited number of U.S ...

The FDA 510(k) clearances for cardiac procedures cover Intuitive's latest-generation da Vinci 5 (DV5) using non-Force ...

Intuitive Surgical has received FDA clearance for cardiac procedures using the da Vinci 5 surgical robot, according to a Jan. 26 report from Mass Device. The new cardiac clearances cover mitral valve ...

CEO Dave Rosa said a strong rollout for the da Vinci 5 surgical robot in 2025 exceeded expectations, with the system driving greater utilization than the earlier Xi model.

Intuitive CEO Dave Rosa highlighted that the clearance related to “several cardiac” procedures for non-force instruments used ...

Intuitive Surgical received FDA clearance for its da Vinci 5 system in selected cardiac procedures, including mitral valve ...

SUNNYVALE, Calif., March 14, 2024 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that ...

Intuitive Surgical's 2025 earnings were strong, and the future remains bright, with valuation as the only big concern for investors.

We came across a bullish thesis on Intuitive Surgical, Inc. on Uncle Stock Notes’s Substack. In this article, we will ...